Dechra Pharmaceuticals

Dechra Pharmaceuticals reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 30 June 2021 at 12 Kt (+0.57/+4.9% y-o-y). At the sime time, carbon intensity declined to 16 t (-1.8 /-10.1% y-o-y).

Dechra Pharmaceuticals's Scope 3 emissions was down at 1.9 Kt (-0.03 /-1.4% y-o-y). The rate of decline has slowed compared to the trend since 2Q'19 (CAGR -3.5%).

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Dechra Pharmaceuticals also has a science-based goal that, however, does not appear to explicitly target a company-wide reduction in emissions in absolute terms. Dechra Pharmaceuticals commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year. Dechra Pharmaceuticals also commits to reduce scope 3 GHG emissions 51.6% per GBP value added within the same timeframe